Facebook
X
LinkedIn
Forward
6th Annual Conference on Psychedelics and Psychedelic Medicine
We invite you to join us at the Starr Center at Massachusetts General Hospital in Boston for our 6th Annual Conference on Psychedelics and Psychedelic Medicine!
Please Note: The conference will be held in Eastern Daylight Time (EDT)
Course Director Franklin King, MD, presents this annual conference as a clinically focused examination of the rapidly evolving field of psychedelic medicine. The program offers up-to-date overviews and critical discussions of current research in psychedelics and psychedelic-assisted therapies, with a clear emphasis on clinical evidence and real-world practice. Sessions will explore proposed mechanisms of action—including pharmacology, neuroscience, and psychodynamic frameworks—while grounding these concepts in the treatment of specific clinical conditions such as depression, PTSD, and substance use disorders. In addition, expert panels and presentations will address ethical considerations, historical context, cultural perspectives, and the role of plant-based medicines, providing clinicians with a balanced, academically rigorous view of this emerging therapeutic landscape.
Virtual Registration
We are also offering a full virtual option to accommodate those who can not attend in person.
For more information and to register, please click the link below.
Register for 2026 Virtual Psychedelics
Pricing
MDs/Doctoral-Level Professionals:
Super Early Bird (on or before June 15, 2026): $525
Early Bird (on or before July 31, 2026): $575
Regular Registration (after July 31, 2026): $600
Other Clinicians:
Super Early Bird (on or before June 15, 2026): $425
Early Bird (on or before July 31, 2026): $475
Regular Registration (after July 31, 2026): $500
Other Professionals: $150.00
Trainees/Students: $100.00
Printed Syllabus
Price: $75.00 (Please note, all syllabus purchases are non-refundable and non-shippable and must be picked up onsite at the conference)
The conference syllabus is a printed book with all slide presentations and space to take notes adjacent to each slide. As an alternative to purchasing a conference syllabus, we provide all attendees with completely free access to all slide presentations in digital PDF format prior to the conference. This is an environmentally friendly alternative and helps keep costs lower for all attendees.
E-Syllabus
We provide all attendees with completely free access to all slide presentations in digital PDF format prior to the conference. This is an environmentally friendly alternative and helps keep costs lower for all attendees. The e-syllabus will be available for 30 days after the conference.
Livestream Troubleshooting Tips.pdf
Cancellation Policy
A refund minus a $100.00 administrative fee will be issued for refund requests received by October 3, 2026. No refunds will be issued for refund requests made after October 3, 2026. Payments made may not be applied to future conferences or other educational activities. There are no exceptions to these policies.
Target Audience
This program is designed for clinicians and researchers across various disciplines who are interested in deepening their understanding of psychedelics, both theoretically and practically. It is open to mental health practitioners such as psychiatrists, psychiatric nurse practitioners, social workers, and clinical psychologists, as well as professionals from other fields who are curious about the applications of psychedelics in clinical and research settings.
Learning Objectives
By the end of this program, participants will be able to:
- Compare different models of psychedelic-assisted psychotherapy (eg, psycholytic vs psychedelic).
- Identify the potential risks of psychedelic-assisted therapies.
- Identify the training and education programs and protocols for Psychedelic Assisted therapies.
- Explain the neuropsychopharmacology of classical psychedelics, as well as atypical psychedelics such as ketamine and empathogens such as MDMA.
- Identify the neuropsychopharmacology of classical psychedelics, as well as atypical psychedelics such as ketamine and empathogens such as MDMA.
- Identify hypotheses for mechanisms of action of psychedelics on the brain, based on recent neuroimaging studies.
- Identify contemporary medico-cultural issues within psychedelic research.
- Critique contemporary medico-cultural issues within psychedelic research, including race-based structural biases and epistemic injustice.
- Identify race-based structural biases and epistemic injustice in psychedelic research.
- Assess potential applications of psychedelic-assisted therapy in extra-psychiatric fields, such as within palliative care and spirituality, as well as within medicine, such as for pain and immunomodulation.
- Discuss the ethical considerations and frameworks necessary for conducting research with psychedelic substances.
- Analyze the current regulatory landscape for psychedelic therapies and their implications for clinical practice.
Accreditation
Check Back Soon for Accreditation Information.
Please come back later for the Agenda.
Hotel Accommodations:
The Liberty, A Marriott Luxury Collection Hotel
215 Charles Street, Boston, MA, 02114, US
We have arranged for a special discounted rate for our valued Psychedelics 2026 attendees. Please book by October 15, 2026, to enjoy this group rate. Room rates are subject to availability. Book now to reserve your space!
You will receive a confirmation email upon registering that will include the booking link for the room block. If you do not receive this email, please contact customer support [email protected]
Check Back Soon for Faculty Information.
Course Director:
Franklin King, MD
Director, Training and Education, Center for Neuroscience of Psychedelics, Massachusetts General Hospital
Instructor in Psychiatry, Harvard Medical School